Kinetics of v-src-induced epithelial-mesenchymal transition in developing glandular stomach

Y Shimizu1, N Yamamichi, K Saitoh

  • 1Division of Host-Parasite Interaction, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Japan.

Oncogene
|February 14, 2003
PubMed

Insights

Oncogene v-src expression in primary epithelial cells triggers migration and mesenchymal marker expression. This process involves MAP kinase signaling and explains why Rous sarcoma virus induces sarcomas, not carcinomas.

Area of Science:

  • Developmental Biology
  • Cell Biology
  • Oncogenesis

Background:

  • The role of oncogenes in primary epithelial cells remains poorly understood.
  • Investigating oncogene function requires specific gene transfer methods into distinct cell types.

Purpose of the Study:

  • To elucidate the function of oncogenes in primary epithelial cells using a novel organ culture system.
  • To investigate the molecular mechanisms underlying oncogene-induced epithelial-mesenchymal transition (EMT).

Main Methods:

  • Utilized recombination organ cultures of developing avian glandular stomach (proventriculus).
  • Employed retroviral and electroporation techniques for stable and transient gene transfer of oncogenes.
  • Analyzed gene expression changes (Sonic hedgehog, E-cadherin, collagen I, fibronectin) and cellular behaviors (migration, apoptosis).

Main Results:

  • Expression of v-src in epithelial cells induced budding and migration into the mesenchyme.
  • Transient v-src or MEK activation led to Sonic hedgehog downregulation and E-cadherin loss, implicating MAP kinase signaling.
  • Continuous v-src expression promoted acquisition of mesenchymal markers and established epithelial-mesenchymal transition (EMT).

Conclusions:

  • Oncogene expression can reprogram epithelial cells, driving migration and EMT.
  • The MAP kinase pathway plays a critical role in mediating oncogene-induced cellular changes.
  • These findings provide insights into the distinct oncogenic outcomes of Rous sarcoma virus (RSV), explaining sarcoma formation.